← All trials
NCT04338906
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2020
- Primary completion
- Jun 1, 2021
- Completion date
- Dec 31, 2021
- First posted
- Apr 8, 2020
- Last posted
- Apr 8, 2020
- Enrollment
- 334
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of DuesseldorfLead sponsor
- J. W. Goethe UniversityCollaborator
- University of HamburgCollaborator
- University of DuesseldorfCollaborator
- University of Applied Sciences Würzburg-SchweinfurtCollaborator
- St. Georg Hospital Leipzig, GermanyCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.